ID

34475

Description

Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01347320

Link

https://clinicaltrials.gov/show/NCT01347320

Keywords

  1. 1/17/19 1/17/19 -
  2. 5/27/19 5/27/19 -
  3. 5/29/19 5/29/19 - Sarah Riepenhausen
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT01347320

Eligibility Prostate Cancer NCT01347320

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients suitable for surgery.
Description

ID.1

Data type

boolean

positive biopsy (gleason grade >3).
Description

ID.2

Data type

boolean

informed consent.
Description

ID.3

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who do not sign the consent paper for any reason or do not accept the study premises.
Description

ID.4

Data type

boolean

patents who want to withdraw for any reason during the study.
Description

ID.5

Data type

boolean

patients with contraindications to mri (pacemaker, claustrophobia etc) and/or surgery.
Description

ID.6

Data type

boolean

patients who have undergone a high quality mri examination of the prostate at another radiological center. in this situation the mr examination is evaluated together with the surgeon but the patient is not included in the study. (in case of a low quality examinations, we will disregard the findings, and include the patient).
Description

ID.7

Data type

boolean

if the surgeon finds it unacceptable to perform ralp without mri, because of various reasons (eg. patient demand, too high risk etc) the patient will not be included in the study.
Description

ID.8

Data type

boolean

if preoperative mri reveals extensive tumor invasion into adjacent organ (t4) or skeletal metastases (m1), as these cancer stadiums do not benefit from ralp.
Description

ID.9

Data type

boolean

Similar models

Eligibility Prostate Cancer NCT01347320

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
all patients suitable for surgery.
boolean
ID.2
Item
positive biopsy (gleason grade >3).
boolean
ID.3
Item
informed consent.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients who do not sign the consent paper for any reason or do not accept the study premises.
boolean
ID.5
Item
patents who want to withdraw for any reason during the study.
boolean
ID.6
Item
patients with contraindications to mri (pacemaker, claustrophobia etc) and/or surgery.
boolean
ID.7
Item
patients who have undergone a high quality mri examination of the prostate at another radiological center. in this situation the mr examination is evaluated together with the surgeon but the patient is not included in the study. (in case of a low quality examinations, we will disregard the findings, and include the patient).
boolean
ID.8
Item
if the surgeon finds it unacceptable to perform ralp without mri, because of various reasons (eg. patient demand, too high risk etc) the patient will not be included in the study.
boolean
ID.9
Item
if preoperative mri reveals extensive tumor invasion into adjacent organ (t4) or skeletal metastases (m1), as these cancer stadiums do not benefit from ralp.
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial